State Street’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

State Street’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-536,802	Closed	-$16.2M	–	3677
2016 Q2	$16.2M	Buy	536,802 +519,302	+2,967%	+$10.5M	﹤0.01%	1906
2016 Q1	$193K	Buy	+17,500	New	+$57.4K	﹤0.01%	3494

State Street's CPXX Position: Q3 2016 in Review

State Street sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 536,802 shares — an estimated $16.2M sold.

State Street first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $16.2M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

State Street reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
State Street sold 536,802 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $16.2M.
State Street first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
State Street's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $16.2M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on State Street's 13F filing for Q3 2016, filed 14 Nov 2016.